Equasens

  • Market Cap: N/A
  • Industry: Software Products
  • ISIN: FR0012882389
EUR
43.50
0.35 (0.81%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Equasens stock-summary
stock-summary
Equasens
Software Products
Pharmagest Interactive SA is a France-based company that develops and integrates management software packages for drugstores. The Company is engaged in the computerization of pharmaceutical dispensaries. Its flagship product is Integrated Portal Management Software, which provides pharmacists with permanent and immediate access to a range of online services and is used for the distribution of information and promotions for pharmaceutical suppliers and for pharmaceutical laboratories. In addition, the Company is engaged in the provision of maintenance services, technologies to manage medication compliance, as well as e-business solutions. It operates through Noviatek, Sailendra, Multimeds, British Caremeds and Axigate, among others.
Company Coordinates stock-summary
Company Details
5 allee de Saint-Cloud, Bp 117 , VILLERS LES NANCY None : 54600
stock-summary
Tel: 33 8 2090810033 03 83159067
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Thierry Chapusot
Chairman of the Board
Mr. Dominique Pautrat
Chief Executive Officer, Member of the Executive Committee, Member of the Board of Directors
Mr. Thierry Ponnelle
Deputy Chief Executive Officer, Director of Commercial Strategy and Marketing, Member of the Board of Directors, Member of the Executive Committee
Mr. Denis Supplisson
Deputy Chief Executive Officer, Member of the Executive Board, Director
Mr. Gregoire de Rotalier
Deputy Managing Director, Director
Mr. Daniel Antoine
Director
Mr. Francois Jacquel
Director
Ms. Emilie Lecomte
Director
Ms. Anne Lhote
Director
Mr. Hugues Moreaux
Representative of La Cooperative Welcoop on the Board of Directors
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
29 Million
(Quarterly Results - Dec 2012)
Net Profit:
stock-summary
Industry

Software Products

stock-summary
Market cap

EUR 634 Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

14.97%

stock-summary
Debt Equity

-0.17

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

2.75